Skip to Main Content

Paper Details

Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors.
Cytotherapy
1
2023
Author NameAffiliation
Heon YooNeuro-Oncology Clinic, National Cancer Center
  • 1 - 1

Datasets

Release 1.2